Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ed Ajootian who wrote (3684)	9/10/1999 12:25:00 PM
From: Biomaven	Read Replies (1) of 10280

People should take a look at the CELG thread for their latest results confirming that their single-isomer version of Ritalin has a longer duration of action than an equivalent dose of the racemate. In this case, a longer duration of action is very significant, as it means no in-school dosing. As I discussed on that thread, the reason for the longer duration of action isn't clear to me - it may be something analogous to Xopenex. This looks to me like a further validation of SEPR's ICE strategy. We'll see if CELG finds a nice US partner soon. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next